Zobrazeno 1 - 10
of 76
pro vyhledávání: '"W M Herrmann"'
Autor:
Leslie S. Prichep, James Halper, F diMichele, Robert Cancro, W M Herrmann, Georg Winterer, T. G. Bolwig, Erwin Roy John
Publikováno v:
Acta Psychiatrica Scandinavica. 116:17-35
Objective: This research sought neurobiological features common to psychotic states displayed by patients with different clinical diagnoses. Method: Cluster analysis with quantitative electroencephalographic (QEEG) variables was used to subtype drug-
Publikováno v:
Pharmacopsychiatry. 33:89-97
A 24-week, double-blind, multi-center, randomised parallel group study compared the efficacy and safety of 800 mg bid cyclandelate with placebo in patients with mild to moderate dementia of primary degenerative or vascular origin. A total of 196 pati
Autor:
W. Wagner, W. M. Herrmann
Publikováno v:
International Journal of Pharmaceutical Medicine. 14:129-136
1. In pharmaceutical medicine, benefit and risk are fundamental, intangible ethical commodities determined normatively in recourse to empirically proven preparation characteristics. As normative value judgements, benefit and risk cannot be offset aga
Publikováno v:
Journal of Dermatological Treatment. 9:175-179
Two features of senescent skin are dryness and itching, which are caused by a reduced water-binding capacity of the stratum corneum. Urea, topically applied, is known to increase the water content of the stratum corneum and thereby improves the sympt
Publikováno v:
Neuropsychobiology. 36:73-82
Two doses of idebenone were studied in a prospective, randomized, double-blind, placebo-controlled multicentre study in patients suffering from dementia of the Alzheimer type (DAT) of mild to moderate degree. Diagnosis was based on DSM-III-R (primary
Publikováno v:
Pharmacopsychiatry. 29:47-56
The efficacy of the Ginkgo biloba special extract EGb 761 in outpatients with presenile and senile primary degenerative dementia of the Alzheimer type (DAT) and multi-infarct dementia (MID) according to DSM-III-R was investigated in a prospective, ra
Publikováno v:
Neuropsychobiology. 32:166-170
The working team 'EEG in Phase I' of the Collegium Internationale Psychiatriae Scalarum presents a standard operating procedure (SOP) for the registration and computer-supported evaluation of pharmaco-EEG data, which is based on published guidelines.
Publikováno v:
Journal of International Medical Research. 21:306-322
In a pilot double-blind trial in 21 patients with learned or idiopathic insomnia (DSM-IIIR), patients received placebo for 1 week (nights 1 – 7), either active (Zolpidem, 10 mg) or placebo treatment for 2 weeks (nights 8 – 21) and then placebo fo
Publikováno v:
Pharmacopsychiatry. 24:206-213